The European Medicines Agency (EMA) Published Safety Monitoring Plan and Guidance on Risk Management Planning for COVID-19 Vaccines
22. November 2020 – The plan prepared by EMA and the national competent authorities (NCAs) in EU Member States, outlines how relevant new information emerging after the authorisation and uptake of COVID-19 vaccines in the pandemic situation will be collected and promptly reviewed.
For further information, see here.